163 related articles for article (PubMed ID: 25633637)
1. A human fetal prostate xenograft model of developmental estrogenization.
Saffarini CM; McDonnell-Clark EV; Amin A; Boekelheide K
Int J Toxicol; 2015; 34(2):119-28. PubMed ID: 25633637
[TBL] [Abstract][Full Text] [Related]
2. Developmental exposure to estrogen alters differentiation and epigenetic programming in a human fetal prostate xenograft model.
Saffarini CM; McDonnell-Clark EV; Amin A; Huse SM; Boekelheide K
PLoS One; 2015; 10(3):e0122290. PubMed ID: 25799167
[TBL] [Abstract][Full Text] [Related]
3. Maturation of the developing human fetal prostate in a rodent xenograft model.
Saffarini CM; McDonnell EV; Amin A; Spade DJ; Huse SM; Kostadinov S; Hall SJ; Boekelheide K
Prostate; 2013 Dec; 73(16):1761-75. PubMed ID: 24038131
[TBL] [Abstract][Full Text] [Related]
4. Effects of testosterone, and testosterone plus estrogen, in the castrated rat ventral prostate--histopathological and immunocytochemical studies.
Murakoshi M; Tagawa M; Inada R; Suzuki M
Tokai J Exp Clin Med; 1992 Oct; 17(3-4):133-7. PubMed ID: 1284451
[TBL] [Abstract][Full Text] [Related]
5. Developmental estrogenization and prostatic neoplasia.
Santti R; Newbold RR; Mäkelä S; Pylkkänen L; McLachlan JA
Prostate; 1994; 24(2):67-78. PubMed ID: 7508622
[TBL] [Abstract][Full Text] [Related]
6. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice.
Prins GS; Birch L; Couse JF; Choi I; Katzenellenbogen B; Korach KS
Cancer Res; 2001 Aug; 61(16):6089-97. PubMed ID: 11507058
[TBL] [Abstract][Full Text] [Related]
7. Developmental estrogen exposures predispose to prostate carcinogenesis with aging.
Prins GS; Birch L; Tang WY; Ho SM
Reprod Toxicol; 2007; 23(3):374-82. PubMed ID: 17123779
[TBL] [Abstract][Full Text] [Related]
8. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
9. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer.
Wang YZ; Wong YC
Prostate; 1998 May; 35(3):165-77. PubMed ID: 9582085
[TBL] [Abstract][Full Text] [Related]
10. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
11. Enhanced induction of prostatic dysplasia and carcinoma in Noble rat model by combination of neonatal estrogen exposure and hormonal treatments at adulthood.
Yuen MT; Leung LK; Wang J; Wong YC; Chan FL
Int J Oncol; 2005 Dec; 27(6):1685-95. PubMed ID: 16273225
[TBL] [Abstract][Full Text] [Related]
12. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
[TBL] [Abstract][Full Text] [Related]
13. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
14. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate.
Scarano WR; Vilamaior PS; Taboga SR
Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov; 288(11):1190-200. PubMed ID: 17031809
[TBL] [Abstract][Full Text] [Related]
15. Comparative pathology of benign prostatic hyperplasia and prostate cancer.
Maini A; Archer C; Wang CY; Haas GP
In Vivo; 1997; 11(4):293-9. PubMed ID: 9292295
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
Jeyaraj DA; Udayakumar TS; Rajalakshmi M; Pal PC; Sharma RS
J Androl; 2000; 21(6):833-41. PubMed ID: 11105909
[TBL] [Abstract][Full Text] [Related]
17. A comparison of prostatic development in xenografts of human fetal prostate and human female fetal proximal urethra grown in dihydrotestosterone-treated hosts.
Cunha GR; Cao M; Franco O; Baskin LS
Differentiation; 2020; 115():37-52. PubMed ID: 32861072
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats.
Tam NN; Szeto CY; Sartor MA; Medvedovic M; Ho SM
Neoplasia; 2008 Jan; 10(1):20-40. PubMed ID: 18231636
[TBL] [Abstract][Full Text] [Related]
19. Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia.
Tam NN; Szeto CY; Freudenberg JM; Fullenkamp AN; Medvedovic M; Ho SM
Mol Endocrinol; 2010 Nov; 24(11):2207-17. PubMed ID: 20861223
[TBL] [Abstract][Full Text] [Related]
20. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
Wang Y; Hayward SW; Donjacour AA; Young P; Jacks T; Sage J; Dahiya R; Cardiff RD; Day ML; Cunha GR
Cancer Res; 2000 Nov; 60(21):6008-17. PubMed ID: 11085521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
